1. Home
  2. |Insights
  3. |Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience

Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience

Firm News | less than 1 min read | 04.21.26

Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.  

Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates. 

The financing transaction was led by partner  Kurt Machemer (Boston). 
 
Read more here. 

Insights

Firm News | 1 min read | 08.24.26

Crowell & Moring Ranked a Leading Firm for Venture Capital Transactions in PitchBook’s Q2 2026 Global League Tables

 August 24, 2026: Crowell & Moring has been ranked in PitchBook’s Q2 2026 Global League Tables among the top law firms for venture capital transactions. These rankings showcase the leading firms in venture capital based on a variety of criteria, including geography, transaction type, and sectors....

View All Insights